Clinical Trial Update: Melatonin for Prevention of Metabolic Side Effects of Olanzapine [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial testing whether melatonin can prevent metabolic side effects from olanzapine in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Melatonin (melatonin)
• olanzapine (olanzapine)

Snippet

Sponsor: Guilan University of Medical Sciences | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED